BRPI1015233A2 - métodos para tratar ou prevenir a fadiga - Google Patents
métodos para tratar ou prevenir a fadigaInfo
- Publication number
- BRPI1015233A2 BRPI1015233A2 BRPI1015233A BRPI1015233A BRPI1015233A2 BR PI1015233 A2 BRPI1015233 A2 BR PI1015233A2 BR PI1015233 A BRPI1015233 A BR PI1015233A BR PI1015233 A BRPI1015233 A BR PI1015233A BR PI1015233 A2 BRPI1015233 A2 BR PI1015233A2
- Authority
- BR
- Brazil
- Prior art keywords
- treat
- methods
- prevent fatigue
- fatigue
- prevent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21908209P | 2009-06-22 | 2009-06-22 | |
| PCT/US2010/039313 WO2011005473A2 (en) | 2009-06-22 | 2010-06-21 | Methods for treating or preventing fatigue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1015233A2 true BRPI1015233A2 (pt) | 2018-02-20 |
Family
ID=43429751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1015233A BRPI1015233A2 (pt) | 2009-06-22 | 2010-06-21 | métodos para tratar ou prevenir a fadiga |
Country Status (13)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5024635B2 (ja) | 2005-06-08 | 2012-09-12 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 睡眠覚醒障害の治療 |
| IN2012DN00624A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 2009-06-22 | 2015-06-12 | Sk Biopharmaceuticals Co Ltd | |
| US8927602B2 (en) * | 2009-11-06 | 2015-01-06 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
| PL2496228T3 (pl) | 2009-11-06 | 2014-06-30 | Sk Biopharmaceuticals Co Ltd | Sposoby leczenia zespołu nadpobudliwości psychoruchowej/deficytu uwagi |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| AU2012359081B2 (en) | 2011-12-21 | 2015-09-17 | Innobioscience, Llc | Combination therapy with interferon and andrographolides for multiple sclerosis |
| TWI684450B (zh) | 2013-03-13 | 2020-02-11 | 南韓商愛思開生物製藥股份有限公司 | 猝倒症之治療 |
| CN105848650A (zh) * | 2013-07-12 | 2016-08-10 | 爵士制药国际Iii有限公司 | 促进吸烟停止 |
| CN105873576B (zh) | 2013-07-18 | 2019-07-19 | 爵士制药国际Iii有限公司 | 治疗肥胖 |
| PL3065751T3 (pl) * | 2013-11-08 | 2020-07-13 | Legacy Healthcare Ltd | Sposób leczenia raka i chorób współistniejących |
| TWI698415B (zh) | 2014-02-28 | 2020-07-11 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
| US10888542B2 (en) | 2014-02-28 | 2021-01-12 | Sk Biopharmaceuticals Co., Ltd. | Aminocarbonylcarbamate compounds |
| JP7219213B2 (ja) | 2016-09-06 | 2023-02-07 | ジャズ ファーマスティカルズ アイルランド リミテッド | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| ES2964943T3 (es) | 2016-10-06 | 2024-04-10 | Axsome Malta Ltd | Compuestos de carbamoilfenilalaninol para uso médico |
| CN110139905B (zh) * | 2016-12-30 | 2021-09-28 | 株式会社东进世美肯 | 涂层组合物及由此制备的薄膜 |
| KR102726728B1 (ko) | 2017-06-02 | 2024-11-05 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 과다 졸림증을 치료하기 위한 방법 및 조성물 |
| CN111094238B (zh) | 2017-07-31 | 2023-06-09 | 杰资制药爱尔兰有限公司 | 氨基甲酰基苯丙氨醇类似物及其用途 |
| JP7428480B2 (ja) * | 2019-06-06 | 2024-02-06 | 雪印メグミルク株式会社 | 睡眠改善用組成物及び組成物を含む食品、医薬品、飼料 |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
| KR102390194B1 (ko) | 2020-08-03 | 2022-04-25 | 셀라이온바이오메드 주식회사 | 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물 |
| KR20240101826A (ko) * | 2021-11-16 | 2024-07-02 | 액섬 몰타 엘티디. | 인지 장애를 치료하기 위한 방법 및 조성물 |
| WO2025006965A1 (en) | 2023-06-29 | 2025-01-02 | Axsome Therapeutics, Inc. | Methods of administering solriamfetol to lactating women |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA943862B (en) | 1993-06-10 | 1995-12-04 | Lilly Co Eli | Method of preventing emesis and treating sexual dysfunction using tetrahydrobenz[cd] indole-6-carboxamides |
| KR100197892B1 (ko) | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
| US5756817C1 (en) | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
| KR0173862B1 (ko) | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| KR0173863B1 (ko) | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| WO1998015626A2 (en) | 1996-10-08 | 1998-04-16 | Institute Of Child Health | Mutant ciita molecule and uses thereof |
| CA2240060C (en) * | 1996-10-10 | 2007-07-17 | Sk Corporation | O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same |
| WO1998017636A1 (en) | 1996-10-22 | 1998-04-30 | Ortho Pharmaceutical Corporation | Phenylalaninol derivatives for the treatment of central nervous system disorders |
| US20040229951A1 (en) | 2003-05-15 | 2004-11-18 | Arthur Vanmoor | Method of treating fatigue by enhancing the effectiveness of the human immune system |
| RU2267319C2 (ru) * | 2003-07-15 | 2006-01-10 | Общество с ограниченной ответственностью "Интер-Кэр" | Фармацевтическая композиция и способ лечения синдрома хронической усталости с ее использованием |
| US20050080268A1 (en) | 2003-10-08 | 2005-04-14 | Yong-Moon Choi | Process of preparing O-carbamoyl compounds in the presence of active amine group |
| CA2587481A1 (en) | 2004-10-28 | 2006-05-11 | Sk Corporation | Phenylalkylamino carbamates adjunctive therapy for depression |
| JP5024635B2 (ja) * | 2005-06-08 | 2012-09-12 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 睡眠覚醒障害の治療 |
| DE602006012670D1 (de) | 2005-06-22 | 2010-04-15 | Sk Holdings Co Ltd | Behandlung der sexuellen dysfunktion |
| JP5094720B2 (ja) | 2005-07-26 | 2012-12-12 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | サブスタンス関連障害を処置する方法 |
| KR20090082213A (ko) | 2006-10-13 | 2009-07-29 | 얀센 파마슈티카 엔.브이. | 페닐알킬아미노 카바메이트 조성물 |
| IN2012DN00624A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 2009-06-22 | 2015-06-12 | Sk Biopharmaceuticals Co Ltd | |
| US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| PL2496228T3 (pl) | 2009-11-06 | 2014-06-30 | Sk Biopharmaceuticals Co Ltd | Sposoby leczenia zespołu nadpobudliwości psychoruchowej/deficytu uwagi |
| US8927602B2 (en) | 2009-11-06 | 2015-01-06 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| TWI684450B (zh) * | 2013-03-13 | 2020-02-11 | 南韓商愛思開生物製藥股份有限公司 | 猝倒症之治療 |
| JP6215740B2 (ja) * | 2014-03-14 | 2017-10-18 | 本田技研工業株式会社 | 部品の締結構造 |
-
2010
- 2010-06-21 IN IN624DEN2012 patent/IN2012DN00624A/en unknown
- 2010-06-21 AU AU2010270971A patent/AU2010270971B2/en active Active
- 2010-06-21 KR KR1020127001795A patent/KR20120098578A/ko not_active Ceased
- 2010-06-21 US US13/379,793 patent/US8741950B2/en active Active
- 2010-06-21 EP EP10797541.9A patent/EP2445490B1/en active Active
- 2010-06-21 CN CN2010800277527A patent/CN102481274A/zh active Pending
- 2010-06-21 MX MX2012000034A patent/MX2012000034A/es active IP Right Grant
- 2010-06-21 JP JP2012517622A patent/JP6095366B2/ja active Active
- 2010-06-21 KR KR1020177020249A patent/KR102021075B1/ko active Active
- 2010-06-21 WO PCT/US2010/039313 patent/WO2011005473A2/en active Application Filing
- 2010-06-21 RU RU2012101947/15A patent/RU2567801C2/ru active
- 2010-06-21 KR KR1020197026173A patent/KR102173587B1/ko active Active
- 2010-06-21 BR BRPI1015233A patent/BRPI1015233A2/pt not_active Application Discontinuation
- 2010-06-21 CA CA2765463A patent/CA2765463C/en not_active Expired - Fee Related
- 2010-06-21 CN CN201710080968.3A patent/CN106727486A/zh active Pending
- 2010-06-22 TW TW099120382A patent/TWI453014B/zh active
-
2014
- 2014-05-07 US US14/271,503 patent/US9464041B2/en active Active
-
2015
- 2015-07-03 JP JP2015134556A patent/JP6368285B2/ja active Active
-
2016
- 2016-09-16 US US15/268,060 patent/US9999609B2/en active Active
-
2018
- 2018-05-18 US US15/983,944 patent/US10507192B2/en active Active
- 2018-07-05 JP JP2018128318A patent/JP2018188450A/ja active Pending
-
2019
- 2019-10-31 US US16/670,382 patent/US20200061017A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1015233A2 (pt) | métodos para tratar ou prevenir a fadiga | |
| BRPI0915476A2 (pt) | dispositivo para tratar problemas respiratórios | |
| BR112012002269A2 (pt) | implemento para tratar superfície | |
| FI20095291L (fi) | Kuitujen käsittely muovausta kestäväksi | |
| BRPI0914614A2 (pt) | 2-arilaminoquinazolinas para tratar doenças proliferativas | |
| BRPI1015403A2 (pt) | válvula | |
| BRPI1011226A2 (pt) | métodos para tratar condições relacionadas ao cabelo | |
| BR112014016292A2 (pt) | montagem de fixação occipito-cervical e método para construir a mesma | |
| BRPI0919127A2 (pt) | métodos para tratamento de água | |
| BRPI1008253A2 (pt) | Metoso para tratar biomassa | |
| BRPI1013361A2 (pt) | método para evitar e tratar hipermeabilidade. | |
| PL2409101T3 (pl) | Stalownia | |
| BR112014009785A2 (pt) | método para tratar ou reduzir efp | |
| BR112014013694A2 (pt) | método para tratar uma doença, e, kit | |
| BR112013008528A2 (pt) | métodos para tratar psoríase | |
| EP2578812A4 (en) | STEAM VALVE | |
| BRPI0822264A2 (pt) | Dapsona para tratar rosácea | |
| FI20096405L (fi) | Teräsrakenteinen ovi | |
| BR112012019786A2 (pt) | processo para prevenir ou atenuar bioincrustação | |
| ES1071426Y (es) | Aparato para tratar un alimento en bloque | |
| BR112012007256A2 (pt) | dispositivo para tratamento de água | |
| BRPI0908014A2 (pt) | método para tratar cabelo | |
| BR112012004071A2 (pt) | tratamento de petróleo | |
| BR112013030090A2 (pt) | métodos para tratar biomassa | |
| EP2515890A4 (en) | NEURAL STIMULATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |